Characteristics of patients after propensity score matching
| Variable . | Prednisone + oral cyclophosphamide . | Prednisone . | P . |
|---|---|---|---|
| n | 70 | 70 | |
| Mean FVIII level at diagnosis, IU/dL (SD) | 4.0 (6.0) | 3.5 (4.1) | .78 |
| Mean inhibitor titer at diagnosis, BU/mL (SD) | 101 (288) | 73 (160) | .37 |
| Mean weight, kg (SD) | 69 (11) | 71 (15) | .41 |
| Etiology, n (%) | |||
| Autoimmune | 10 (14) | 11 (16) | .62 |
| Idiopathic | 48 (69) | 48 (69) | |
| Malignancy | 8 (11) | 8 (11) | |
| Pregnancy | 4 (5.7) | 3 (4.3) | |
| Mean age, y (SD) | 72 (14) | 71 (17) | .52 |
| Sex, no. (%) | |||
| Female | 33 (47) | 32 (46) | .86 |
| Male | 37 (53) | 38 (54.) | |
| Mean steroid dose, mg/kg (SD) | 1.18 (0.38) | 1.33 (2.12) | .006 |
| Variable . | Prednisone + oral cyclophosphamide . | Prednisone . | P . |
|---|---|---|---|
| n | 70 | 70 | |
| Mean FVIII level at diagnosis, IU/dL (SD) | 4.0 (6.0) | 3.5 (4.1) | .78 |
| Mean inhibitor titer at diagnosis, BU/mL (SD) | 101 (288) | 73 (160) | .37 |
| Mean weight, kg (SD) | 69 (11) | 71 (15) | .41 |
| Etiology, n (%) | |||
| Autoimmune | 10 (14) | 11 (16) | .62 |
| Idiopathic | 48 (69) | 48 (69) | |
| Malignancy | 8 (11) | 8 (11) | |
| Pregnancy | 4 (5.7) | 3 (4.3) | |
| Mean age, y (SD) | 72 (14) | 71 (17) | .52 |
| Sex, no. (%) | |||
| Female | 33 (47) | 32 (46) | .86 |
| Male | 37 (53) | 38 (54.) | |
| Mean steroid dose, mg/kg (SD) | 1.18 (0.38) | 1.33 (2.12) | .006 |
Comparison of the propensity score-matched groups of prednisone alone and prednisone + oral cyclophosphamide. The groups were matched for all characteristics except steroid dose, where the prednisone alone group received a higher dose/kg than the prednisone + cyclophosphamide group.